癌症研究
肺癌
奥西默替尼
表皮生长因子受体
医学
抗药性
药理学
癌症
埃罗替尼
内科学
生物
微生物学
作者
Ke-Ren Zhang,Yu-Fei Zhang,Hui-Min Lei,Ya-Bin Tang,Chunshuang Ma,Qian-Ming Lv,Wang Shi-yi,Liming Lu,Ying Shen,Hongzhuan Chen,Liang Zhu
出处
期刊:Science Translational Medicine
[American Association for the Advancement of Science (AAAS)]
日期:2021-10-06
卷期号:13 (614)
被引量:63
标识
DOI:10.1126/scitranslmed.abg6428
摘要
AKR1B1 boosts glutathione de novo synthesis as a metabolic mechanism driving resistance to EGFR-targeted therapy in mouse models of lung cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI